DJIA 16,374.76 23.38 0.14%
NASDAQ 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
market minute promo

Gilead Sciences (NASDAQ: GILD)

101.91 -2.36 (-2.26%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $101.91 -2.26%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.92
Previous Close $104.27
Daily Range $101.69 - $105.00
52-Week Range $85.95 - $123.37
Market Cap $149.6B
P/E Ratio 10.96
Dividend (Yield) $1.72 (1.6%)
Ex-Dividend Date
Dividend Pay Date
09/14/15
09/29/15
Volume 9,905,932
Average Daily Volume 11,753,587
Current FY EPS $11.99

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

3 Biotech Stocks to Buy in the Middle of a Turbulent Market

Take advantage of the market turmoil with these biotech stocks.

Gilead Reports Encouraging Data on TAF-based HIV Regimen

Incyte & Hengrui to Develop Anti-PD-1 Monoclonal Antibody

Aberdeen Asset Management: A Dividend Growth Bargain With High Yield To Add To The Young And Cautiou

Aberdeen Asset Management: A Dividend Growth Bargain With High Yield To Add To The Young And Cautious Portfolio

Here Are a Few Stocks With Fat Profit Margins

Gilead Sciences: Under $105 A Share Is A Gift

Gilead Sciences' 11% Drop in August Could Make It a Steal

An industrywide selloff in biotech and fears of growing competition may be creating a buy opportunity in Gilead Sciences.

AstraZeneca Strikes Deal with Valeant for Psoriasis Drug

Illumina Acquires GenoLogics, Boosts Genomic Sequencing

Meet The Manager Of A Top Performing Mutual Fund

See More GILD News...

GILD's Top Competitors

GILD $101.91 (-2.26%)
Current stock: GILD
AMGN $149.23 (-2.01%)
Current stock: AMGN
CELG $117.65 (-1.61%)
Current stock: CELG
$0.00 (0.00%)
Current stock: